News | August 16, 2022
QIAGEN launches syndromic test for QIAstat-Dx device to combat Monkeypox health emergency
QIAstat-Dx Viral Vesicular Panel tests for six pathogens that produce similar symptoms
QIAstat-Dx Viral Vesicular Panel tests for six pathogens that produce similar symptoms
CerTest Biotec uses the BD MAX molecular diagnostic system open system reagent suite to develop RT-PCR detection kit
TLANDO was approved by the U.S. Food and Drug Administration (FDA) on March 28, 2022.
Lung cancer is the leading cause of cancer death in the USA, making up almost 25% of all cancer deaths
Roche and its subsidiary TIB Molbiol have developed three different LightMix Modular Virus kits for the detection of the virus
This cost-effective tool will be of immense benefit to other high burden countries as well.
City of Hope is first in world to test oncolytic virus, CF33-hNIS, in people with metastatic solid tumours
Revolutionary ovarian cancer rapid test available Q4 2022
NextSWAB is currently optimized for nasal sample collection with validation for other sample types ongoing
Digital PCR format allows for rapid turnaround time to facilitate fast and accurate post-transplant treatment decisions
Subscribe To Our Newsletter & Stay Updated
